Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioAmber Inc. BIOAQ

BioAmber Inc is an industrial biotechnology company producing renewable chemicals. The company's proprietary technology platform combines industrial biotechnology and chemical catalysis to convert bio-based feedstocks into renewable chemicals that are cost-competitive replacements for petroleum-derived chemicals used in a wide variety of everyday products including plastics, resins, paints, food additives and personal care products. BioAmber produces bio-succinic acid at a facility in Sarnia, On


OTCPK:BIOAQ - Post by User

Comment by GngLongon Apr 09, 2018 2:26pm
233 Views
Post# 27854369

RE:WHOOO.

RE:WHOOO.Oh Ricky Rick Flair - lets summarize what we know. 
They have enough cash to get them to June, then they are either going Bankrupt or further diluting the stock with yet another offering (to whom, god only knows). The problem with further diluting is that they have already screwed their shareholders so many times, we're raw (who in the right mind would execute their warrants now?). So they need to find new shareholders to F***. Hence the R/S..... WITH AN INCREASE in A/S (kinda ironic, no?).

Of course to get the facts straight, they have handed out so many warrants that they don't have enough A/S to cover them, and therefore would have to pay penalties if holders actually wanted to execute their outstanding warrants. 

The timing of everything is going to be interesting. The increase in A/S really has to happen, but the R/S is totally for the sake of relisting on a major exchange. If they could find a magical way to get EPS in positive territory, than fine, but 2017 EPS was -$2.34. After a 100x R/S that's $234 loss on a $3.50 stock, if we use today's numbers.


<< Previous
Bullboard Posts
Next >>